|
Comparison of intranasal hypertonic Dead Sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis.
From:
Ear, Nose and Throat Journal
| Date:
July 1, 2005| Author:
Cordray, Scott; Harjo, Jim B.; Miner, Linda
| COPYRIGHT 2005 Vendome Group LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
Abstract
Intranasal corticosteroids are well known to be efficacious in the treatment of allergic rhinitis. Nasal irrigation with saline, including hypertonic saline, has long been recommended for the treatment of sinonasal disease, and it has been shown to have a positive effect on the physiology of the nasal mucosa. Until now, no study of the clinical efficacy of intranasal hypertonic Dead Sea saline as a monotherapyfor seasonal allergic rhinitis has been reported. We ...
Related newspaper, magazine, and journal articles from HighBeam Research
|
Pediatric allergic rhinitis: factors affecting treatment choice.
Ear, Nose and Throat Journal
; Abstract Allergic rhinitis is the most prevalent chronic allergic disease in children. Although it is not life-threatening, it can have a significantly detrimental effect on a child's quality of life, and it may exacerbate a number of common comorbidities, including asthma and sinusitis. The
|
|
The most common allergy: allergic rhinitis.(nasal allergies - causes, effects, and relief)(The Allergy Report 1998 - sponsored supplement - American Academy of Allergy, Asthma and Immunology)
Discover
; Two weeks after the fall school term started, Mrs. Davidson brought her 16-year-old daughter Linda to their doctor. Linda was miserable: Her itchy, stuffy, runny nose was making her cough and keeping her up at night, and she could only breathe through her mouth. She had lost her sense of smell and
|
|
Allergic rhinitis affects sleep quality in adults.(Tips from Other Journals)(Clinical report)
American Family Physician
; Background: A significant portion of the general population has symptoms secondary to allergic rhinitis, and those who have allergic rhinitis tend to have lower scores on quality-of-life surveys. Sleep disorders are also common and have a significant impact on quality of life. Studies have shown a
|
|
A clinical review of montelukast in the treatment of seasonal allergic rhinitis
Formulary
; Abstract Seasonal allergic rhinitis is a disease characterized by sneezing, nasal congestion, rhinorrhea, and itching, conventionally treated with intranasal corticosteroids and anti-histamines. The leukotriene receptor antagonist montelukast (Singulair, Merck) recently gained FDA approval for the
|
|
Intranasal corticosteroids for first-line treatment of allergic rhinitis: What's the evidence?
Formulary
; ABSTRACT Treatment of allergic rhinitis includes avoidance of allergens and, in many patients, prescription medications to control symptoms. Antihistamines are considered by guidelines to be first-line therapy for most patients, largely due to their perceived advantage in onset of action. However,
|